Apr 01, 2024 7:50am EDT NEXGEL Reports Full Year 2023 Revenue of $4.1 Million, an Increase of 99.7% Year-Over-Year
Mar 27, 2024 9:00am EDT NEXGEL Reschedules Fourth Quarter and Full Year 2023 Financial Results Conference Call to Monday, April 1st at 8:30 a.m. ET Due to Holiday
Mar 21, 2024 9:00am EDT NEXGEL to Report Fourth Quarter and Full Year 2023 Financial Results on March 28th
Mar 04, 2024 8:30am EST NEXGEL to Present at the iAccess Alpha Best Ideas Spring Virtual Conference on March 12th
Jan 18, 2024 9:00am EST NEXGEL to Present at The Microcap Conference, January 30th through February 1st
Jan 09, 2024 8:30am EST NEXGEL Subsidiary, CG Converting and Packaging, Begins 12,000 Square Foot Expansion of Texas Facility to Support the Expected Growth in Product Demand in 2024
Dec 11, 2023 8:00am EST NEXGEL Announces Partnership with STADA to Distribute and Commercialize Consumer Health OTC Products in North America
Nov 13, 2023 4:05pm EST NEXGEL Reports Record Third Quarter 2023 Revenue of $1.2 Million, an Increase of 115% Year-Over-Year
